Running the UK’s largest integrated beef supply chain, the Buitelaar Group are industry leading livestock experts, passionate for making continuous improvement to assist farmers through current and future industry challenges. Engaging in R&D and modern farming methods, Buitelaar Group have provided the trials platform for the ImmunIGY test, (Long Lane Development Farm) and run trials across supply chain calves under the experienced and singularly coordinated rearing team in conjunction with the dedicated Buitelaar Trials Committee.

Soma Bioscience is a UK based company with expertise in Lateral Flow based test development and manufacture. They have developed a range of tests to measure proteins and hormones in human saliva, including the world's first and only commercially available salivary cortisol test. which are deployed by many Premier League and Champions League soccer clubs as well as National Teams in many sports. Recent work has been towards the veterinary sector, by developing a test for Campylobacter in poultry and IgA and cortisol in dogs and horses. They are the developer of the ImmunIgY Bovine IgG test and also manufacture these tests in Oxfordshire, UK.

Synergy Farm Health Limited is an independently owned, dedicated farm only veterinary practice based in the Southwest of England.  Employing 45 veterinary surgeons and a large team of veterinary technicians, the practice provides clinical and consultancy services to its client base and also delivers training, education, research and consultancy to the wider industry. A high number of veterinary surgeons hold postgraduate and specialist qualifications.

The novel ImmunIGy test was initiated and co-developed at Synergy Farm Health in response to the need to improve health and reduce antimicrobial use within its clients’ calf rearing systems. Intrinsic to this is the need for calf rearers to understand at the point of entry onto their units, which calves have robust levels of immunity as a result of good colostrum supply at birth, and which calves are likely to be prone to disease due a failure of passive transfer.